Tapeworm Drug May Hold Promise For Colon Cancer, Future Research
Wednesday, November 4, 2009 - 07:49
in Health & Medicine
(PhysOrg.com) -- Duke University Medical Center researchers have discovered an already-FDA-approved compound that can effectively `silence` a cell receptor shown to interfere with chemotherapy.
Read the whole article on Physorg
More from Physorg
Related
- Class of antibiotics can enhance gene-silencing toolSun, 20 Jul 2008, 16:21:35 EDT
- Light scattering technology may hold promise for quickly determining chemotherapy's effectivenessTue, 21 Apr 2009, 15:37:34 EDT
- Chemotherapy might help cancer vaccines workThu, 15 May 2008, 21:28:40 EDT
- Looking beyond the drug receptor for clues to drug effectivenessMon, 25 Aug 2008, 17:36:46 EDT
- First compound for receptors in schizophrenia and Alzheimer's holds promiseMon, 20 Apr 2009, 13:43:04 EDT